A wireless implant helped patients with severe macular degeneration regain usable vision. The results point toward a new ...
ANNX advances tanruprubart for Guillain-Barré syndrome, with an EMA filing planned for January 2026 and ongoing FDA ...
By reducing inflammation, the researchers were able to prevent both the buildup of immune cells and the formation of these ...
The overall dry AMD market size in the US is anticipated to increase, due to the uptake of recently approved therapies, the launch of emerging therapies such as Gildeuretinol (Alkeus Pharmaceuticals), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback